Skip to main content

Zyvox News

FDA Medwatch Alert: Linezolid Injection by Auromedics Pharma: Voluntary Recall 600mg/300mL flexible bags- Due to Presence White Particle Matter That Has Been Identified as Mold

ISSUE: AuroMedics Pharma is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch...

FDA Medwatch Alert: Zyvox (linezolid): Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications

ISSUE: FDA has received reports of serious central nervous system (CNS) reactions when the antibacterial drug linezolid (Zyvox) is given to patients taking psychiatric medications that work through...

FDA Medwatch Alert: Zyvox (linezolid)

[Posted 03/16/2007] FDA notified healthcare professionals of new emerging safety concerns about Zyvox (linezolid) from a recent clinical study. This open-label, randomized trial compared linezolid to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Methicillin-Resistant Staphylococcus Aureus Infection, Bacterial Infection, Skin and Structure Infection, Pneumonia

Zyvox patient information at Drugs.com